Connor Clark & Lunn Investment Management Ltd. Purchases 185,364 Shares of Avantor, Inc. (NYSE:AVTR)

Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 34.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 717,729 shares of the company's stock after purchasing an additional 185,364 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.11% of Avantor worth $15,123,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after buying an additional 625 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after acquiring an additional 830 shares during the last quarter. Global Retirement Partners LLC raised its stake in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock valued at $52,000 after acquiring an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after purchasing an additional 1,074 shares during the period. Finally, AlphaQuest LLC bought a new stake in shares of Avantor in the fourth quarter worth $65,000. 95.08% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts recently issued reports on AVTR shares. UBS Group reaffirmed a "neutral" rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Barclays cut their price objective on Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Raymond James reissued an "outperform" rating and set a $24.00 target price (down previously from $26.00) on shares of Avantor in a research report on Monday, February 10th. Stifel Nicolaus dropped their price target on shares of Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research report on Monday, February 10th. Finally, Morgan Stanley reduced their price objective on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $25.50.

Insider Activity

In related news, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP James Bramwell sold 3,758 shares of the firm's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company's stock.

Avantor Stock Up 1.4 %

NYSE:AVTR traded up $0.23 during trading hours on Monday, reaching $16.53. The company had a trading volume of 5,267,638 shares, compared to its average volume of 6,238,945. The business's 50-day simple moving average is $19.51 and its two-hundred day simple moving average is $22.01. Avantor, Inc. has a twelve month low of $15.37 and a twelve month high of $28.00. The firm has a market cap of $11.25 billion, a price-to-earnings ratio of 15.89, a P/E/G ratio of 1.55 and a beta of 1.30. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period last year, the business posted $0.22 earnings per share. On average, equities analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.